Related Experiment Videos
A fluorogenic allele-specific amplification method for DNA-based screening for inherited metabolic disorders.
Y Matsubara1, K Fujii, P Rinaldo
1Department of Medical Genetics, Tohoku University School of Medicine, Aobaku, Sendai, Japan. ymats@mail.cc.tohoku.ac.jp
Acta Paediatrica (Oslo, Norway : 1992). Supplement
|January 8, 2000
Summary
A new TaqMan-allele-specific amplification (ASA) method enables rapid, automated DNA diagnosis for inherited metabolic diseases. This real-time PCR technique simplifies neonatal screening by detecting specific mutations without post-PCR steps.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Mutation databases for inherited metabolic diseases are expanding, necessitating efficient DNA diagnostic methods for neonatal screening.
- Current DNA diagnostic methods may not be suitable for high-throughput sample processing required for large-scale screening.
- Developing a simple, automatable DNA diagnostic technique is crucial for advancing neonatal screening programs.
Purpose of the Study:
- To develop a simple, automatable DNA diagnostic method for detecting point mutations in inherited metabolic diseases.
- To adapt allele-specific amplification (ASA) using a fluorogenic probe (TaqMan probe) for real-time fluorescence monitoring.
- To validate the TaqMan-ASA method for its suitability in neonatal screening applications.
Main Methods:
- Devised an allele-specific amplification (ASA) method incorporating a TaqMan probe for point mutation detection.
- Utilized pairwise PCR amplification with two sets of allele-specific primers and real-time fluorescence monitoring.
- Employed threshold cycle differences to distinguish between mutant and normal alleles, performed on an ABI PRISM 7700 sequence detector.
Main Results:
- The TaqMan-ASA method demonstrated real-time fluorescence monitoring to differentiate mutant and normal alleles based on amplification efficiency.
- The technique eliminates the need for post-PCR processing, thereby preventing potential PCR contamination.
- Successfully applied TaqMan-ASA to detect a g727t mutation in Japanese patients with glycogen storage disease type Ia and an a985g mutation in Caucasian patients with medium-chain acyl-CoA dehydrogenase deficiency.
Conclusions:
- TaqMan-ASA is a simple, automatable DNA diagnostic method suitable for processing large numbers of samples in a 96-well microtiter plate format.
- The method effectively detects specific point mutations relevant to inherited metabolic diseases, facilitating neonatal screening.
- TaqMan-ASA offers a robust and efficient approach for genetic diagnosis in inherited metabolic diseases, potentially improving early detection and management.